Background illustration for clinical trials search

Paid Clinical Trials Oakland

Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: Stanford CA, Los Angeles CA, La Jolla CA, Gilbert AZ,
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT06051695

Phase1, Phase2, Recruiting
Active & Responsive

Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis

for
Osteonecrosis of the Femoral Head,
Location: Stanford CA, Los Angeles CA, Minneapolis MN,
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT06123481

Recruiting
Active & Responsive

Bumetanide in Patients With Alzheimer's Disease

for
Alzheimer Disease
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 50 - 70+

Code: NCT06052163

Phase2, Recruiting
Active & Responsive

Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping

for
Huntington Disease
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT06941662

Recruiting
Active & Responsive

Imaging Synapses With [11C] UCB-J in the Human Brain

for
Schizophrenia
Location: Stanford CA, Palo Alto CA
Sponsor: Davidzon, Guido, M.D.

Sex: All

Age: 18 - 65

Code: NCT04038840

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

for
Spinal Muscular Atrophy Type 3,
Location: Palo Alto CA, New York NY, Boston MA
Sponsor: Columbia University

Sex: All

Age: 5+

Code: NCT06839469

Recruiting
Active & Responsive

GBPDC: Gut-Brain in PD Consortium Master Protocol

for
Parkinson Disease (PD), PARKINSON DISEASE (Disorder),
Location: Stanford CA, Rochester MN, Chicago IL
Sponsor: Duke University

Sex: All

Age: 21 - 70+

Code: NCT07567794

Recruiting
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Palo Alto CA, Los Angeles CA, Salt Lake City UT,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase2, Recruiting
Active & Responsive

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

for
Hemophilia A
Location: Palo Alto CA, San Diego CA, Oklahoma City OK,
Sponsor: Wayne State University

Sex: All

Age: 6 - 19

Code: NCT05022459

Recruiting
Active & Responsive

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1)
Location: Stanford CA, Denton TX, Iowa City IA, St Louis MO,
Sponsor: Dyne Therapeutics

Sex: All

Age: 18 - 65

Code: NCT05481879

Phase1, Phase2, Recruiting
Active & Responsive

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

for
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\),
Location: Stanford CA, Los Angeles CA, Dallas TX, Saint Paul MN,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 5

Code: NCT06503367

Recruiting
Active & Responsive

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis

for
Osteoarthritis Shoulder, Shoulder Pain
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 25 - 70+

Code: NCT04929951

Phase1, Recruiting
Active & Responsive

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

for
Lymphoblastic Leukemia
Location: Palo Alto CA, Madera CA, Los Angeles CA, Orange CA,
Sponsor: Tanja Andrea Gruber

Sex: All

Age: 0 - 1

Code: NCT05848687

Phase1, Phase2, Recruiting
Active & Responsive

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

for
Autism Spectrum Disorder (ASD), Autism
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 6 - 12

Code: NCT06627205

Recruiting
Active & Responsive

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

for
Immunization; Infection, Transplantation Infection, Influenza
Location: Stanford CA, Kansas City MO, Houston TX, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 17

Code: NCT05947071

Phase2, Recruiting
Active & Responsive

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

for
Refractory Acute Myeloid Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06561152

Phase1, Phase2, Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Stanford CA, Los Angeles CA, Portland OR,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

for
Acute Myeloid Leukemia
Location: Stanford CA, Duarte CA, Salt Lake City UT, Phoenix AZ,
Sponsor: Norman J. Lacayo

Sex: All

Age: 0 - 21

Code: NCT05101551

Phase1, Recruiting
Active & Responsive

Study of Cryoablation and Nirogacestat for Desmoid Tumor

for
Desmoid Tumor
Location: Palo Alto CA
Sponsor: Nam Bui

Sex: All

Age: 18+

Code: NCT05949099

Phase2, Recruiting
Active & Responsive

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis (AD)
Location: Fremont CA, West Hills CA, Santa Monica CA,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07298395

Phase2, Recruiting